Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-7-16
pubmed:abstractText
A recent study found that variation in camptothecin pharmacodynamic genes (TOP1, PARP1, TDP1 and XRCC1) correlated with efficacy and risk of neutropenia in irinotecan-treated cancer patients (median dose: 180 mg/m2), which suggests that these genes might predict outcomes to irinotecan-based therapies. The present study was conducted to evaluate previous gene associations using an independent sample of patients receiving irinotecan.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-10744089, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-11006366, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-11156391, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-11791212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-11815397, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-11990381, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-14576839, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-14699148, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15007088, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15175435, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15280927, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15286088, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15297419, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15342424, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15379698, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15469406, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15494395, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15705867, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-15970793, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-16030121, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-16271446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-16508634, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-17184208, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-17728214, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-18347181, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-9653159, http://linkedlifedata.com/resource/pubmed/commentcorrection/19604089-9739812
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1744-8042
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1139-46
pubmed:dateRevised
2011-6-14
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.
pubmed:affiliation
UNC Institute for Pharmacogenomics & Individualized Therapy, University of North Carolina, Genetic Medicine Building, Chapel Hill, NC 27599-7360, USA. janelle_hoskins@unc.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural